Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

Vaccine

Volumn 14, Issue 10, 1996, Pages 1001-1008

  Claassen, Ivo ^a   Meylis, Jolanda ^a   Van Der Ley, Peter ^a   Peeters, Carla ^a   Brons, Hans ^a   Robert, Jolanda ^a   Borsboom, Dominique ^a   Van Der Ark, Arno ^a   Van Straaten, Ineke ^a   Roholl, Paul ^a   Kuipers, Betsy ^a   Poolman, Jan ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM PHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; DEOXYCHOLIC ACID; EPITOPE; IMMUNOLOGICAL ADJUVANT; MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; PLACEBO; THIOMERSAL;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINE PRODUCTION;

EID: 0030197578     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00020-5     Document Type: Article

References (29)

1. 1 Scholten, R.J.P.M., Bijlmer, H.A., Poolman, J.T. et al. Meningococcal disease in The Netherlands, 1958-1990. Steady increase of the incidence rate since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. J. Clin. Infect. 1993, 16, 237-246
2. 2 Peltola, H. Meningococcal disease: still with us. Rev. Infect. Dis. 1984, 5, 71-91
3. 3 Wyle, F.E., Artenstein, M.S., Brandt, B.L. et al. Immunological response in man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 1972, 126, 514-522
4. 4 Jennings, H.J., Roy, R. and Gamian, A. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice using an N-proprionylated B polysaccharide tetanus toxoid conjugated vaccine. J. Immunol. 1986, 37, 1708-1713
5. 5 Zollinger, W.D., Boslego, J., Moran, E. et al. Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. NIPH Ann. 1991, 14, 211-213
6. 6 Bjune, G., Høiby, E.A., Grønnesby, J.K. et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991, 338, 1093-1096
7. 7 de Moraes, J.C., Perkins, B.A., Camargo, M.C. et al. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 1992, 340, 1074-1078
8. 8 Høiby, E.A., Rosenqvist, E.A., Frøholm, L.O. et al. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann. 1991, 14, 147-156
9. 9 Saukkonnen, K., Leinonen, M., Abdillahi, H. and Poolman, J.T. Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 1989, 7, 325-328
10. 10 Abdillahi, H. and Poolman, J.T. Neisseria meningitidis group B serosubtyping using monoclonal antibodies whole-cell ELISA. Microbiol. Pathogen. 1988, 4, 27-32
11. 11 Van der Ley, P.A. and Poolman, J.T. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 1992, 60, 3156-3161
12. 12 Van der Ley, P.A., Van der Biezen, J. and Poolman, J.T. Construction of Neisseria Meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane protein vaccine. Vaccine 1995, 13, 401-407
13. 13 Rosenqvist, E., Høiby, E.A., Wedege, E., Kuseck, B. and Achtman, M. The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies. J. Infect. Dis. 1993, 167, 1065-1073
14. 14 Aho, E.L., Dempsey, J.A., Hobbs, M.M., Klapper, D.G. and Cannon, D.G. Characterization of the opA (class 5) gene family of Neisseria meningitidis. Mol. Microbiol. 1991, 5, 1429-1437
15. 15 Rosenqvist, E., Høiby, E.A., Wedege, E. et al. A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microb. Pathogen. 1993, 15, 197-205
16. 16 Legrain, M., Mazarin, V., Irwin, S.W. et al. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin binding proteins Tbp1 and Tbp2. Gene 1993, 130, 73-80
17. 17 Petterson, A., Kuipers, A.J., Pelzer, M. et al. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect. Immun. 1990, 58, 3036
18. 18 Peeters, C.C.A.M., Rümke, H.C., Sundermann, L.C. et al. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 1996. in press
19. 19 Frantz, I.D. Growth requirements of the meningococcus. J. Bact. 1942, 43, 757-761
20. 20 Frederiksen, J.H., Rosenqvist, E., Wedege, E. et al. Production, characterization and control of MenB-vaccine 'Folkehelsa': an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 1991, 14, 67-80
21. 21 Peterson, G.L. A simplification of the protein assay of Lowry et al. which is more generally applicable. Anal. Biochem. 1977, 83, 346-356
22. 22 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 277, 680-685
23. 23 Wray, W., Boulikas, T., Wray, V.P. and Hancock, R. Silver staining of proteins in polyacrylamide gels. Anal. Biochem. 1981, 118, 197-203
24. 24 Tsai, C., Boykins, R. and Frasch, C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 1982, 119, 115-119
25. 25 Bryn, K. and Jantzen, E. Analysis of lipopolysaccharides by methanolysis, trifluoroacetylation and gas chromatography on a fused-silica capillary column. J. Chromatogr. 1982, 240, 405-413
26. 26 Wedege, E., Dalseg, R., Caugant, D.A., Poolman, J.T. and Frøholm, L.O. Expression of an inaccessible P1.7 subtype on meningococcal class 1 proteins. J. Med. Microbiol. 1993, 38, 23-28
27. 27 Wedege, E., Bjune, G., Frøholm, L.O., Høiby, E.A. and Rosenvist, E. Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial. NIPH Ann. 1991, 14, 183-186
28. 28 Poolman, J.T., Van der Ley, P.A., Wiertz, E.J.H.J. and Hoogerhout, P. Second generation meningococcal OMP-LPS vaccines. NIPH Ann. 1991, 14, 233-241
29. 29 Poolman, J.T., Timmermans, J.A.M., Hopman, C.T.P. et al. Comparison of meningococcal outer membrane protein vaccines, solubilized with detergent or C polysaccharide. Antonie van Leeuwenhoek 1987, 53, 557-564